VHL (VHL, Von Hippel-Lindau disease tumor suppressor, Protein G7, PVHL)

Full length fusion protein corresponding to human VHL

Suitable for use in ELISA, Western Blot and Immunohistochemistry. Other applications not tested.

Von Hippel-Lindau syndrome (VHL) is a dominantly inherited familial cancer syndrome predisposing to a variety of malignant and benign tumors. A germline mutation of this gene is the basis of familial inheritance of VHL syndrome. The protein encoded by this gene is a component of the protein complex that includes elongin B, elongin C, and cullin-2, and possesses ubiquitin ligase E3 activity.

IgG

Polyclonal

Purified by immunoaffinity chromatography.

Suitable for use in ELISA, Western Blot and Immunohistochemistry. Other applications not tested.

ELISA: 1:2000-1:5000 Western Blot: 1:500-1:2000 Immunohistochemistry: 1:50-1:200 Optimal dilutions to be determined by the researcher.

Rabbit

Hu

Recognizes human VHL

P40337